MedPath
TGA Approval

BIVALIRUDIN MEDICIANZ bivalirudin (as trifluoroacetate) 250 mg powder for injection vial (427181)

427181

BIVALIRUDIN MEDICIANZ bivalirudin (as trifluoroacetate) 250 mg powder for injection vial

Medsurge Pharma Pty Ltd

July 9, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

bivalirudin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIVALIRUDIN MEDICIANZ bivalirudin (as trifluoroacetate) 250 mg powder for injection vial (427181) - TGA 批准文号 | MedPath